Viral hepatitis, type B. Studies on natural history and prevention re-examined
- PMID: 758598
- DOI: 10.1056/NEJM197901183000301
Viral hepatitis, type B. Studies on natural history and prevention re-examined
Abstract
Frozen serial serum specimens obtained from past studies on the natural history and prevention of Type B hepatitis in children were retested by radioimmunoassay for the following markers of hepatitis B infection: hepatitis B surface antigen (HBsAg) and antibody (anti-HBs), hepatitis B e antigen (HBeAg) and antibody (anti-HBe), and antibody to hepatitis B core antigen (anti-HBc). The interval between exposure and evidence of viremia (HBsAg) was as short as six days. HBsAg and HBeAg persisted for two to five months and occasionally for more than one year after recovery. After the disappearance of their respective antigens, anti-HBc and anti-HBs persisted for more than seven years and anti-HBe for one to two years. Treatment with hepatitis B immune globulin after exposure induced complete or partial protection or prolongation of the incubation period. Administration of heat-inactivated hepatitis B virus, MS-2 strain, to 29 children induced an inapparent infection in three, characterized by a transient appearance of HBsAg and HBeAg, and the persistence of anti-HBc, anti-HBe and anti-HBs for more than two years.
Similar articles
-
[Viral markers of hepatitis A and B: main characteristics and clinical significance].Arq Gastroenterol. 1983 Jul-Sep;20(3):117-22. Arq Gastroenterol. 1983. PMID: 6329145 Portuguese.
-
Viral hepatitis type B: propects for active immunization.Dev Biol Stand. 1975;30:363-7. Dev Biol Stand. 1975. PMID: 1204971
-
Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.Gastroenterology. 1983 Jul;85(1):163-7. Gastroenterology. 1983. PMID: 6406288
-
[Markers of type B viral hepatitis].Minerva Med. 1979 Sep 26;70(41):2791-800. Minerva Med. 1979. PMID: 386166 Review. Italian.
-
Rational use of hepatitis B immune globulin.Scand J Infect Dis. 1977;9(2):67-9. doi: 10.3109/inf.1977.9.issue-2.02. Scand J Infect Dis. 1977. PMID: 331461 Review.
Cited by
-
The one year effects of three doses of hepatitis B vaccine as a booster in anti-HBs-negative children 11-15 years after primary immunization; China, 2009-2011.Hum Vaccin Immunother. 2015;11(5):1114-9. doi: 10.4161/21645515.2014.987001. Hum Vaccin Immunother. 2015. PMID: 25692413 Free PMC article. Clinical Trial.
-
Solid-phase radioimmunoassay for hepatitis Be antigen (HBeAg).Klin Wochenschr. 1979 Oct 15;57(20):1129-32. doi: 10.1007/BF01481494. Klin Wochenschr. 1979. PMID: 92593
-
The Heat Stability of Hepatitis B Virus: A Chronological Review From Human Volunteers and Chimpanzees to Cell Culture Model Systems.Front Cell Infect Microbiol. 2020 Feb 4;10:32. doi: 10.3389/fcimb.2020.00032. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32117806 Free PMC article. Review.
-
Hepatitis vaccines.Indian J Pediatr. 1981 Nov-Dec;48(395):685-8. doi: 10.1007/BF02758527. Indian J Pediatr. 1981. PMID: 7346403 No abstract available.
-
Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report.Turk J Gastroenterol. 2018 May;29(3):259-269. doi: 10.5152/tjg.2018.18263. Turk J Gastroenterol. 2018. PMID: 29755010 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous